Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Review

Randomized Controlled Trial

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Multicenter Study

Comparative Study

Clinical Trial, Phase II

Case Reports

Observational Study

Publication Year

From

Quick links

Individual year

2021

2017

2013

2012

2011

2007

2006

2005

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Foscarnet""[mesh_terms]

13 Results

Searching titles within these results

Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients.

Isabelle T Nguyen, Walter Domingo, Joyce J Johnsrud, Janice Wes Brown

Transplantation and cellular therapy 2021;27(7):622.e1-622.e5

Free Full Text

Abstract

Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.

Steve Clissold, Jim Curtis, Jackie Slipper, Alan Boyd, Andrea Bacigalupo

Expert review of anti-infective therapy 2013;10(11):1249-64

Full Text

Abstract

Evidence that the first strand-transfer reaction of duck hepatitis B virus reverse transcription requires the polymerase and that strand transfer is not needed for the switch of the polymerase to the elongation mode of DNA synthesis.

Yunhao Gong, Ermei Yao, John E Tavis, Melissa Stevens

The Journal of general virology 2000;81(Pt 8):2059-2065

Full Text

Abstract

Phosphate transporters of the SLC20 and SLC34 families.

Ian C Forster, Nati Hernando, Jürg Biber, Heini Murer

Molecular aspects of medicine 2013;34(2-3):386-95

Free Full Text

Abstract

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.

T Katagiri, S Nakao, M Yamaguchi, T Hoshino, T Yoshida, K Ishiyama

Bone marrow transplantation 2011;46(6):863-9

Full Text

Abstract

Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.

Yan-Xing Han, Rong Xue, Wei Zhao, Zhen-Xian Zhou, Jian-Nong Li, Hong-Shan Chen, Xiang-Hong Chen, Yan-Ling Wang, Yu-Huan Li, Yin-Wei Wu, Xue-Fu You, Li-Xun Zhao, Jian-Dong Jiang

Antiviral research 2006;68(3):147-53

Full Text

Abstract

Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.

J T Holbrook, M D Davis, L D Hubbard, B K Martin, G N Holland, D A Jabs, A K Gilpin, C Meinert, D S Reshef

Archives of ophthalmology (Chicago, Ill. : 1960) 2000;118(9):1196-204

Full Text

Abstract

Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections.

G M Wool, T W Cheung, D T Jayaweera, D Pearce, P Benson, R Nahass, C Olson

International journal of STD & AIDS 2001;11(10):640-7

Full Text

Abstract

A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.

M M Huycke, M T Naguib, M M Stroemmel, K Blick, K Monti, S Martin-Munley, C Kaufman

Antimicrobial agents and chemotherapy 2000;44(8):2143-8

Free Full Text

Abstract

Progressive outer retinal necrosis presenting with isolated optic neuropathy.

E U Dorotheo, V Biousse, R A Tang, J S Schiffman, N J Newman, B K Nakamoto

Neurology 2005;63(12):2423-5

Full Text

Abstract

Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.

K Ishiyama, T Katagiri, K Ohata, K Hosokawa, Y Kondo, H Yamazaki, A Takami, S Nakao

Transplant infectious disease : an official journal of the Transplantation Society 2012;14(1):33-9

Full Text

Abstract

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

Evan B Shereck, Erin Cooney, Carmella van de Ven, Phyllis Della-Lotta, Mitchell S Cairo

Pediatric blood & cancer 2007;49(3):306-12

Full Text

Abstract

Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.

Scott D Schoenberger, Stephen J Kim, Jennifer E Thorne, Prithvi Mruthyunjaya, Steven Yeh, Sophie J Bakri, Justis P Ehlers

Ophthalmology 2017;124(3):382-392

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Foscarnet""[mesh_terms]

Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients.

Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.

Evidence that the first strand-transfer reaction of duck hepatitis B virus reverse transcription requires the polymerase and that strand transfer is not needed for the switch of the polymerase to the elongation mode of DNA synthesis.

Phosphate transporters of the SLC20 and SLC34 families.

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.

Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.

Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.

Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections.

A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.

Progressive outer retinal necrosis presenting with isolated optic neuropathy.

Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.

Results for
""Foscarnet""[mesh_terms]